BioCentury | Jan 6, 2021
Finance

Senti banks $105M series B as Bayer continues to show enthusiasm for gene and cell therapy biotechs

...could align strategically with the pharma’s future priorities.Other new investors in the series B included Matrix Partners...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...round led by RTW Investments and GT Fund with participation by existing investors CBC Group, Matrix Partners...
BioCentury | Dec 9, 2020
Emerging Company Profile

How D3 Bio is building its biomarker-driven pipeline

...a syndicate of investors including Boyu Capital, Matrix Partners...
...employees: UndisclosedFunds raised: $200 millionInvestors: Boyu Capital, Matrix Partners...
BioCentury | Dec 9, 2020
Emerging Company Profile

Tallac: linking antibodies to DNA-triggered innate immunity

...round included venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners...
...millionInvestors: venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners...
BioCentury | Nov 17, 2020
Finance

D3 Bio’s debut with $200M series A highlights China’s fast-track to global stage

...$200 million series A round Tuesday backed by a syndicate of investors including Boyu Capital, Matrix Partners...
BioCentury | Oct 29, 2020
Finance

Oct. 28 Quick Takes: Mirati raises $800M on KRAS data; BMS-insitro, Novartis-Molecular Partners, Genecast, Gracell, PureTech, Cerevel, Biodesix

...affiliate GL Ventures, Suzhou Zhongmengxin, Huaxing Capital and previous investors including China Capital Investment Group, Matrix Partners...
BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...round co-led by Tencent, GL Ventures and YF Capital with participation by Morningside Venture Capital, Matrix Partners...
BioCentury | Apr 17, 2020
Emerging Company Profile

Rgenta: enhancing interactions between RNA and RNA-binding proteins

...partners: N/A Number of employees: 6 Funds raised: $20 million Investors: Boehringer Ingelheim Venture Fund, Matrix Partners...
BioCentury | Apr 3, 2020
Product Development

April 2 Quick Takes: Horizon takes out Curzion; plus Rgenta, Merck, Novartis-Aurobindo, Kite, Teneobio and Seattle Genetics

...Rgenta Therapeutics announced a $20 million seed round led by Boehringer Ingelheim Venture Fund and Matrix Partners...
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...B round from new investors Mayo Clinic and NTT Venture Capital, and from existing investors Matrix Partners...
Items per page:
1 - 10 of 22
BioCentury | Jan 6, 2021
Finance

Senti banks $105M series B as Bayer continues to show enthusiasm for gene and cell therapy biotechs

...could align strategically with the pharma’s future priorities.Other new investors in the series B included Matrix Partners...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...round led by RTW Investments and GT Fund with participation by existing investors CBC Group, Matrix Partners...
BioCentury | Dec 9, 2020
Emerging Company Profile

How D3 Bio is building its biomarker-driven pipeline

...a syndicate of investors including Boyu Capital, Matrix Partners...
...employees: UndisclosedFunds raised: $200 millionInvestors: Boyu Capital, Matrix Partners...
BioCentury | Dec 9, 2020
Emerging Company Profile

Tallac: linking antibodies to DNA-triggered innate immunity

...round included venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners...
...millionInvestors: venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners...
BioCentury | Nov 17, 2020
Finance

D3 Bio’s debut with $200M series A highlights China’s fast-track to global stage

...$200 million series A round Tuesday backed by a syndicate of investors including Boyu Capital, Matrix Partners...
BioCentury | Oct 29, 2020
Finance

Oct. 28 Quick Takes: Mirati raises $800M on KRAS data; BMS-insitro, Novartis-Molecular Partners, Genecast, Gracell, PureTech, Cerevel, Biodesix

...affiliate GL Ventures, Suzhou Zhongmengxin, Huaxing Capital and previous investors including China Capital Investment Group, Matrix Partners...
BioCentury | Oct 6, 2020
Deals

Oct. 5 Quick Takes: BridgeBio reacquiring Eidos, Amgen KRAS data, after-hours tumbles for Iovance, Y-mAbs and more

...round co-led by Tencent, GL Ventures and YF Capital with participation by Morningside Venture Capital, Matrix Partners...
BioCentury | Apr 17, 2020
Emerging Company Profile

Rgenta: enhancing interactions between RNA and RNA-binding proteins

...partners: N/A Number of employees: 6 Funds raised: $20 million Investors: Boehringer Ingelheim Venture Fund, Matrix Partners...
BioCentury | Apr 3, 2020
Product Development

April 2 Quick Takes: Horizon takes out Curzion; plus Rgenta, Merck, Novartis-Aurobindo, Kite, Teneobio and Seattle Genetics

...Rgenta Therapeutics announced a $20 million seed round led by Boehringer Ingelheim Venture Fund and Matrix Partners...
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...B round from new investors Mayo Clinic and NTT Venture Capital, and from existing investors Matrix Partners...
Items per page:
1 - 10 of 22